BiotechTube
Home/Celloram/John Letterio, M.D.
JL

John Letterio, M.D.

Co-founder and Board Director

Celloram

Therapeutic Areas

CancerAutoimmune DisordersMetabolic Disorders

Celloram Pipeline

DrugIndicationPhase
CLM-022Not Specified (Oncology/Immune/Metabolic Focus)Preclinical
SopprimerexNot Specified (Oncology/Immune/Metabolic Focus)Preclinical
NOVS-100Not Specified (Oncology/Immune/Metabolic Focus)Preclinical
ProtexiNot Specified (Oncology/Immune/Metabolic Focus)Preclinical

Leadership Team at Celloram

TP
Tej Pareek, PhD, MBA, MPH
President, CEO, Board Director
SK
Seong-Jin Kim, PhD
Co-founder and Board Director
SL
Seunghwan Lim, PhD
VP and Director Scientific Operations, Cell Therapy Program
LL
Liraz Levi, PhD
VP and Director Scientific Operations, Small Molecule Program
S(
Sarah (Saerom) Kim
Business Development Advisor
View full Celloram profile